Vagisil Anti-itch Medicated Wipes Maximum Strength Cloth
NDC Package 11509-5035-1
Package Information
Vagisil Anti-itch Medicated Wipes Maximum Strength (pramoxine hydrochloride) cloths is adults and children12 years and older Unfold towelette and gently pat or wipe external vaginal area from front to back. This formulation utilizes a cloth delivery system. Marketed by Combe Incorporated, this product is identified by NDC 11509-5035 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 1039541 - pramoxine HCl 1 % Medicated Pad
- RxCUI: 1039541 - pramoxine hydrochloride 10 MG/ML Medicated Pad
- RxCUI: 1039541 - pramoxine hydrochloride 1 % Medicated Pad
- RxCUI: 1039541 - pramoxine hydrochloride 1 % Medicated Wipe
- RxCUI: 1039550 - Vagisil 1 % Medicated Pad
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 11509 - Combe Incorporated
- 11509-5035 - Vagisil Anti-itch Medicated Wipes Maximum Strength
- 11509-5035-1 - 12 PACKET in 1 CARTON / 4.5 g in 1 PACKET
- 11509-5035 - Vagisil Anti-itch Medicated Wipes Maximum Strength
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 11509-5035-1 identifies a specific commercial package of 12 packet in 1 carton / 4.5 g in 1 packet of Vagisil Anti-itch Medicated Wipes Maximum Strength, a human over the counter drug labeled by Combe Incorporated. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This cloth is formulated for topical use and contains pramoxine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Combe Incorporated on June 28, 2005. The current certification is valid through December 31, 2026.
How is this Combe Incorporated product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 11509503501. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.